BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15283799)

  • 1. Aplasia cutis congenita after methimazole exposure in utero.
    Karg E; Bereg E; Gaspar L; Katona M; Turi S
    Pediatr Dermatol; 2004; 21(4):491-4. PubMed ID: 15283799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero.
    Iwayama H; Hosono H; Yamamoto H; Oshiro M; Ueda N
    Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):680-4. PubMed ID: 17803201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor.
    Abe M; Syuto T; Yokoyama Y; Ishikawa O
    Int J Dermatol; 2010 Mar; 49(3):334-5. PubMed ID: 20465676
    [No Abstract]   [Full Text] [Related]  

  • 4. Aplasia cutis congenita after exposure to methimazole: a causal relationship?
    Vogt T; Stolz W; Landthaler M
    Br J Dermatol; 1995 Dec; 133(6):994-6. PubMed ID: 8547058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
    Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy.
    Rodríguez-García C; González-Hernández S; Hernández-Martín A; Pérez-Robayna N; Sánchez R; Torrelo A
    Pediatr Dermatol; 2011; 28(6):743-745. PubMed ID: 21995270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aplasia cutis congenita following in utero methimazole exposure.
    Baid SK; Merke DP
    J Pediatr Endocrinol Metab; 2007 May; 20(5):585-6. PubMed ID: 17642418
    [No Abstract]   [Full Text] [Related]  

  • 8. Aplasia cutis congenita and skull defects after exposure to methimazole in utero.
    Nakamura S; Nishikawa T; Isaji M; Ishimori M; Shimizu N; Iwamura M; Nishikawa Y; Kubo M; Totani R
    Intern Med; 2005 Nov; 44(11):1202-3. PubMed ID: 16357464
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bilateral renal agenesis (Potter's syndrome) in a girl born to a hyperthyroid mother who received methimazole in early pregnancy].
    Rodríguez-García R
    Ginecol Obstet Mex; 1999 Dec; 67():587-9. PubMed ID: 10692809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible teratogenic effects of thiamazole].
    Ozgen HM; Reuvers-Lodewijks WE; Hennekam RC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(2):101-4. PubMed ID: 16440566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aplasia cutis as a teratogenic effect of methimazole].
    Díez-Delgado Rubio J; Belmonte Martín MJ; Calvo Bonachera MD; López Candel E
    An Esp Pediatr; 1999 Sep; 51(3):290-2. PubMed ID: 10575754
    [No Abstract]   [Full Text] [Related]  

  • 12. Malformations following methimazole exposure in utero: an open issue.
    Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
    Bowman P; Osborne NJ; Sturley R; Vaidya B
    QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of aplasia cutis congenita following in utero exposure to carbimazole].
    Kojmane W; Atmani S
    Ann Dermatol Venereol; 2020 Jan; 147(1):76-77. PubMed ID: 31818499
    [No Abstract]   [Full Text] [Related]  

  • 18. Aplasia cutis congenita and methimazole.
    Bachrach LK; Burrow GN
    Can Med Assoc J; 1984 May; 130(10):1264. PubMed ID: 6722686
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated alpha-fetoprotein in pregnancy complicated by aplasia cutis after exposure to methimazole.
    Farine D; Maidman J; Rubin S; Chao S
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):996-7. PubMed ID: 2453822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.